Abstract
Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Current Respiratory Medicine Reviews
Title:Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries
Volume: 12 Issue: 1
Author(s): Bill Brashier
Affiliation:
Keywords: Occupational asthma, developing countries, work-aggravated asthma.
Abstract: Occupational asthma (OA) has emerged as the commonest occupational lung disease in developed countries and the second commonest in developing countries. Nearly 9-15% of the global adult asthma is occupation associated. However, this is an underestimation as large proportion of occupational asthma remains unidentified in developing world. The economic burden of OA is enormous but the disease is potentially preventable. The western models of documenting and legislation implementation models have provided a scaffold to curb various occupation morbidities of the world. Many government and non-government bodies along pertinent political inclination have been instrumental in the risk factor identification and sensitizer dose assessment for OA in the developed countries, and also ensuring that patients are adequately treated and compensated by the employers, with execution of good ergonomic practices in work places. The characteristic of OA epidemiology in developing world is contrary to the poor diagnosis, inappropriate treatment and inadequate compensation, with lack of political will. This mandates necessity of learning from developed country occupational disease models context to understanding of OA, along with reliable and feasible diagnostics and interventions that will have the potential to minimize the health hazards from the exposures at workplace environments in developing countries.
Export Options
About this article
Cite this article as:
Brashier Bill, Occupational Exposure and Occupational Asthma: Difference in Practices in Developed Countries v/s Developing Countries, Current Respiratory Medicine Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573398X11666151028205538
DOI https://dx.doi.org/10.2174/1573398X11666151028205538 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
Current Pharmaceutical Design Medicinal Chemistry of N-Acylhydrazones: New Lead-Compounds of Analgesic, Antiinflammatory and Antithrombotic Drugs
Current Medicinal Chemistry Asafoetida, Natural Medicine for Future
Current Nutrition & Food Science Systemic Vasculitis: An Epidemiological Perspective
Current Immunology Reviews (Discontinued) Novel Aspects of Insulin-like Growth Factor 1/insulin Network in Chronic Inflammatory Airway Disease
Current Medicinal Chemistry Hypersensitivity Reactions to Last Generation Chimeric, Umanized and Human Recombinant Monoclonal Antibodies for Therapeutic Use
Current Pharmaceutical Design RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes
Current Gene Therapy The Nature of Immunological Reaction in the Peripheral Airways of Cigarette Smokers
Current Respiratory Medicine Reviews Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back
Inflammation & Allergy - Drug Targets (Discontinued) Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Gastrin-Releasing Peptide Receptor as a Molecular Target for Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Real Time Analysis of Neurotransmitters in the Brain Using a Micro-Electrode System
Current Neurovascular Research Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Current Topics in Medicinal Chemistry Evidence For A Functional Contribution of Adenosine Signalling in Inflammatory Airway Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Oral Beclomethasone Dipropionate: A Critical Review of its Use in the Management of Ulcerative Colitis and Crohn’s Disease
Current Clinical Pharmacology Long-Term Bronchodilator Inhaled Therapy in COPD: The Role of Tiotropium Bromidum
Reviews on Recent Clinical Trials A2B Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Editorial [Hot Topic: Comparative Biochemistry of Molecular Targets for Drug and Pesticides: N-Acetyl-D-glucosamine and Acetylcholine Related Enzymes (Guest Editor: Qing Yang )]
Current Drug Targets Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry